SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

Search

Bertrandt AG

Open

14.9 -0.13

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

14.62

Max

15.04

Schlüsselkennzahlen

By Trading Economics

Einkommen

51M

-2.8M

Verkäufe

-1.7M

234M

EPS

-0.99

Gewinnspanne

-1.181

Angestellte

11,932

EBITDA

-3.5M

12M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+40.37% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

13. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-3.4M

176M

Vorheriger Eröffnungskurs

15.03

Vorheriger Schlusskurs

14.9

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Bertrandt AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. März 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23. März 2026, 22:55 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23. März 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23. März 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23. März 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23. März 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23. März 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Global Equities Roundup: Market Talk

23. März 2026, 22:42 UTC

Market Talk
Wichtige Nachrichtenereignisse

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23. März 2026, 22:40 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23. März 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23. März 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23. März 2026, 22:21 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23. März 2026, 22:20 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23. März 2026, 22:19 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23. März 2026, 22:18 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23. März 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23. März 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23. März 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23. März 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23. März 2026, 21:32 UTC

Ergebnisse

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23. März 2026, 21:10 UTC

Wichtige Nachrichtenereignisse

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23. März 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23. März 2026, 20:50 UTC

Market Talk
Ergebnisse
Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Bertrandt AG Prognose

Kursziel

By TipRanks

40.37% Vorteil

12-Monats-Prognose

Durchschnitt 21 EUR  40.37%

Hoch 21 EUR

Tief 21 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bertrandt AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

19 / 19.38Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bertrandt AG

Bertrandt Aktiengesellschaft provides engineering services. It operates through three segments: Digital Engineering, Physical Engineering, and Electrical Systems/Electronics. The Digital Engineering segments designs vehicle components for interior, exterior, powertrain, chassis, or body, as well as the development of complete vehicles, including numerical analysis. Its Physical Engineering segment combines all the activities related to the validation of physical components parts, components, systems, powertrains, and the vehicle. This segment also offers validation services that include cover testing, road tests, modelling, vehicle structure, rapid prototyping, and rapid tooling services. The Electrical Systems/Electronics segment develops electronic modules, such as batteries, e- drivetrains, onboard networks, as well as provides software development and simulated deployment, and autonomous driving services. It also engages in the testing, planning, project management, and CAD activities. The company serves automotive, aerospace, mechanical and plant engineering, electrical, energy, and medical engineering sectors. It operates in approximately 50 locations in Germany, rest of Europe, Asia, Africa, and the United States. Bertrandt Aktiengesellschaft was founded in 1974 and is headquartered in Ehningen, Germany.
help-icon Live chat